Descriptor English: | Primaquine | ||||
Descriptor Spanish: |
Primaquina
| ||||
Descriptor Portuguese: | Primaquina | ||||
Descriptor French: | Primaquine | ||||
Entry term(s): |
Diphosphate, Primaquine Phosphate, Primaquine Primacin Primaquine Diphosphate Primaquine Phosphate |
||||
Tree number(s): |
D03.633.100.810.050.650 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D011319 | ||||
Scope note: | An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404) |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Antimalarials |
||||
Registry Number: | MVR3634GX1 | ||||
CAS Type 1 Name: | 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)- | ||||
DeCS ID: | 11755 | ||||
Unique ID: | D011319 | ||||
NLM Classification: | QV 258 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1966/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Primaquine
- Preferred
Primaquine Phosphate
- Narrower
Primacin
- Narrower
Primaquine Diphosphate
- Narrower
Concept UI |
M0017573 |
Scope note | An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404) |
Preferred term | Primaquine |
Concept UI |
M0017575 |
Preferred term | Primaquine Phosphate |
Entry term(s) |
Phosphate, Primaquine |
Concept UI |
M0475721 |
Preferred term | Primacin |
Concept UI |
M0329757 |
Preferred term | Primaquine Diphosphate |
Entry term(s) |
Diphosphate, Primaquine |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey